Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases

被引:0
作者
Juszczuk, Klaudia [1 ]
Grudlewska, Katarzyna [1 ]
Mikucka, Agnieszka [1 ]
Gospodarek-Komkowska, Eugenia [1 ]
机构
[1] Uniwersytet Mikolaja Kopernika Toruniu, Coll Med Bydgoszczy, Katedra & Zaklad Mikrobiol, Ul Barycka 37G, PL-86005 Biale Blota, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2017年 / 71卷
关键词
Clostridium difficile; recurrent Clostridium difficile infection; fecal microbiota transplantation; stool transplantation; diarrhea; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INTESTINAL MICROBIOTA; DONOR FECES; FLORA; BACTERIOTHERAPY; COMMENSAL; CHILDREN; THERAPY; ENEMA;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clostridium difficile is a serious epidemiological problem and particularly dangerous microorganism causing hospital infections. Currently, the treatment of C. difficile infections is the use of metronidazole or vancomycin. However, in some patients, recurrent infection difficult to treat occurs. Fecal microbiota transplantation (FMT) is a new method used to treat the recurrent CDI. FMT consists in the infusion of the fecal suspension from a healthy donor into the gastrointestinal tract of a patient with CDI to restore the natural intestinal microflora. FMT is safe and effective treatment of recurrent CDI. FMT is extensively described around the world, but to date only two randomized studies confirming the effectiveness of FMT have been conducted. This method was also applied in the treatment of diseases such as pseudomembranous colitis, ulcerative colitis, Crohn's disease and irritable bowel syndrome. The review describes the procedure for FMT and the current state of knowledge about the effectiveness of FMT in the treatment of recurrent CDI.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 63 条
  • [1] Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
    Aas, J
    Gessert, CE
    Bakken, JS
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 580 - 585
  • [2] Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity
    Adams, James B.
    Johansen, Leah J.
    Powell, Linda D.
    Quig, David
    Rubin, Robert A.
    [J]. BMC GASTROENTEROLOGY, 2011, 11
  • [3] Ananthaswamy A., 2011, NEW SCI ISSUE, V2796, P19
  • [4] Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease
    Anderson, J. L.
    Edney, R. J.
    Whelan, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (06) : 503 - 516
  • [5] ANDREWS PJ, 1992, EUR J GASTROEN HEPAT, V4, P245
  • [6] Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]
  • [7] Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
    Atarashi, Koji
    Tanoue, Takeshi
    Shima, Tatsuichiro
    Imaoka, Akemi
    Kuwahara, Tomomi
    Momose, Yoshika
    Cheng, Genhong
    Yamasaki, Sho
    Saito, Takashi
    Ohba, Yusuke
    Taniguchi, Tadatsugu
    Takeda, Kiyoshi
    Hori, Shohei
    Ivanov, Ivaylo I.
    Umesaki, Yoshinori
    Itoh, Kikuji
    Honda, Kenya
    [J]. SCIENCE, 2011, 331 (6015) : 337 - 341
  • [8] Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands
    Bauer, M. P.
    Veenendaal, D.
    Verhoef, L.
    Bloembergen, P.
    van Dissel, J. T.
    Kuijper, E. J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) : 1087 - 1092
  • [9] BENNET JD, 1989, LANCET, V1, P164
  • [10] Bieiec D., 2014, POST N MED, V27, P770